nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—SLC6A2—locus ceruleus—narcolepsy	0.0941	0.329	CbGeAlD
Dexmedetomidine—SLC6A2—autonomic nervous system—narcolepsy	0.05	0.175	CbGeAlD
Dexmedetomidine—ADRA1D—forebrain—narcolepsy	0.0189	0.066	CbGeAlD
Dexmedetomidine—SLC6A2—brainstem—narcolepsy	0.0121	0.0422	CbGeAlD
Dexmedetomidine—SLC6A2—forebrain—narcolepsy	0.0117	0.0408	CbGeAlD
Dexmedetomidine—SLC6A2—medulla oblongata—narcolepsy	0.00842	0.0294	CbGeAlD
Dexmedetomidine—ADRA2A—forebrain—narcolepsy	0.00824	0.0288	CbGeAlD
Dexmedetomidine—ADRA1B—brain—narcolepsy	0.008	0.028	CbGeAlD
Dexmedetomidine—ADRA1D—brain—narcolepsy	0.00783	0.0274	CbGeAlD
Dexmedetomidine—ADRA2C—medulla oblongata—narcolepsy	0.00746	0.0261	CbGeAlD
Dexmedetomidine—ADRA2C—midbrain—narcolepsy	0.00682	0.0238	CbGeAlD
Dexmedetomidine—CYP2D6—brainstem—narcolepsy	0.00661	0.0231	CbGeAlD
Dexmedetomidine—CYP2D6—forebrain—narcolepsy	0.00638	0.0223	CbGeAlD
Dexmedetomidine—ADRA2A—medulla oblongata—narcolepsy	0.00595	0.0208	CbGeAlD
Dexmedetomidine—CYP2E1—medulla oblongata—narcolepsy	0.00582	0.0204	CbGeAlD
Dexmedetomidine—ADRA2A—midbrain—narcolepsy	0.00544	0.019	CbGeAlD
Dexmedetomidine—SLC6A2—brain—narcolepsy	0.00483	0.0169	CbGeAlD
Dexmedetomidine—ADRA2C—brain—narcolepsy	0.00428	0.015	CbGeAlD
Dexmedetomidine—CYP1A1—brain—narcolepsy	0.00367	0.0128	CbGeAlD
Dexmedetomidine—ADRA2A—brain—narcolepsy	0.00342	0.012	CbGeAlD
Dexmedetomidine—CYP2E1—brain—narcolepsy	0.00334	0.0117	CbGeAlD
Dexmedetomidine—CYP2D6—brain—narcolepsy	0.00265	0.00926	CbGeAlD
Dexmedetomidine—ADRA1B—G alpha (q) signalling events—NPS—narcolepsy	0.00233	0.00326	CbGpPWpGaD
Dexmedetomidine—ADRA1B—G alpha (q) signalling events—TAC1—narcolepsy	0.00233	0.00326	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—HCRT—narcolepsy	0.00232	0.00325	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00231	0.00324	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00231	0.00324	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—PENK—narcolepsy	0.00229	0.00321	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00224	0.00314	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00221	0.00309	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00217	0.00304	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—HCRT—narcolepsy	0.00217	0.00304	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00216	0.00302	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HCRTR2—narcolepsy	0.00215	0.003	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HCRTR1—narcolepsy	0.00215	0.003	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—HCRT—narcolepsy	0.00213	0.00299	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00212	0.00297	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00208	0.00292	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00208	0.00292	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—P2RY11—narcolepsy	0.00207	0.0029	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—PENK—narcolepsy	0.00207	0.0029	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00206	0.00289	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00203	0.00284	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—TRH—narcolepsy	0.00195	0.00273	CbGpPWpGaD
Dexmedetomidine—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.00193	0.00271	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—PENK—narcolepsy	0.00193	0.00271	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—PENK—narcolepsy	0.0019	0.00266	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00189	0.00265	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00186	0.00261	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00186	0.0026	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00186	0.0026	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00179	0.00251	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00177	0.00248	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00177	0.00248	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.00176	0.00247	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—TRH—narcolepsy	0.00176	0.00246	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00175	0.00245	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00172	0.0024	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00171	0.00239	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—HRH3—narcolepsy	0.00171	0.00239	CbGpPWpGaD
Dexmedetomidine—ADRA1D—G alpha (q) signalling events—HTR2A—narcolepsy	0.00169	0.00237	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00168	0.00235	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00168	0.00235	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—TRH—narcolepsy	0.00164	0.0023	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.00162	0.00227	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00161	0.00225	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00161	0.00225	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.0016	0.00224	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.0016	0.00224	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.00157	0.0022	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00157	0.0022	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00157	0.0022	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—P2RY11—narcolepsy	0.00155	0.00217	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00154	0.00216	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00154	0.00216	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—P2RY11—narcolepsy	0.00154	0.00216	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—HRH3—narcolepsy	0.00154	0.00216	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00154	0.00215	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00151	0.00212	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.00149	0.00209	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.00149	0.00209	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00147	0.00206	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00147	0.00206	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HCRT—narcolepsy	0.00145	0.00203	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HCRTR2—narcolepsy	0.00145	0.00203	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HCRTR1—narcolepsy	0.00145	0.00203	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—P2RY11—narcolepsy	0.00144	0.00202	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—HRH3—narcolepsy	0.00144	0.00202	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00142	0.00199	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.00142	0.00199	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—NPS—narcolepsy	0.00142	0.00198	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—TAC1—narcolepsy	0.00142	0.00198	CbGpPWpGaD
Dexmedetomidine—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.0014	0.00196	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—P2RY11—narcolepsy	0.0014	0.00196	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HCRTR2—narcolepsy	0.00136	0.0019	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HCRTR1—narcolepsy	0.00136	0.0019	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00133	0.00187	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00133	0.00187	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00133	0.00187	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00132	0.00185	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00132	0.00185	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00132	0.00185	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HCRT—narcolepsy	0.00131	0.00184	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—P2RY11—narcolepsy	0.00131	0.00183	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00131	0.00183	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.0013	0.00181	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.00129	0.0018	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—NPS—narcolepsy	0.00128	0.00179	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—TAC1—narcolepsy	0.00128	0.00179	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00127	0.00178	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00127	0.00178	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00125	0.00176	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HCRT—narcolepsy	0.00123	0.00172	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00121	0.0017	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00121	0.0017	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.00121	0.00169	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—TAC1—narcolepsy	0.00119	0.00167	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—NPS—narcolepsy	0.00119	0.00167	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HCRT—narcolepsy	0.00119	0.00167	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00118	0.00165	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.00118	0.00165	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.00118	0.00165	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.00118	0.00165	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.00117	0.00164	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.00117	0.00164	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—PENK—narcolepsy	0.00117	0.00164	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00117	0.00163	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00112	0.00157	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HCRT—narcolepsy	0.00111	0.00156	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.0011	0.00154	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0011	0.00154	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.0011	0.00154	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.0011	0.00154	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.0011	0.00153	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00109	0.00153	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—PENK—narcolepsy	0.00109	0.00153	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CHKB—narcolepsy	0.00109	0.00152	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00108	0.00152	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.00108	0.00151	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.00106	0.00149	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—PENK—narcolepsy	0.00106	0.00149	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00101	0.00141	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.001	0.0014	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.000995	0.00139	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—TRH—narcolepsy	0.000994	0.00139	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—PENK—narcolepsy	0.000992	0.00139	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.000976	0.00137	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.00097	0.00136	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.00097	0.00136	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.000966	0.00135	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.000949	0.00133	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.000949	0.00133	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000943	0.00132	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—TRH—narcolepsy	0.000929	0.0013	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000928	0.0013	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.000917	0.00128	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.000914	0.00128	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.000904	0.00127	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—TRH—narcolepsy	0.000903	0.00126	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000894	0.00125	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.000887	0.00124	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CHKB—narcolepsy	0.000883	0.00124	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.000877	0.00123	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HRH3—narcolepsy	0.000872	0.00122	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HCRTR2—narcolepsy	0.000857	0.0012	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HCRTR1—narcolepsy	0.000857	0.0012	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.000852	0.00119	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000844	0.00118	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000844	0.00118	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—TRH—narcolepsy	0.000843	0.00118	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.00083	0.00116	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—P2RY11—narcolepsy	0.000828	0.00116	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HRH3—narcolepsy	0.000814	0.00114	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CHKB—narcolepsy	0.000811	0.00114	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.000806	0.00113	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.000802	0.00112	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HCRTR2—narcolepsy	0.000801	0.00112	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HCRTR1—narcolepsy	0.000801	0.00112	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.0008	0.00112	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.0008	0.00112	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HRH3—narcolepsy	0.000792	0.00111	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.000788	0.0011	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.000788	0.0011	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.00078	0.00109	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—P2RY11—narcolepsy	0.000773	0.00108	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR ligand binding—HTR2A—narcolepsy	0.000769	0.00108	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000766	0.00107	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CHKB—narcolepsy	0.000765	0.00107	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.000761	0.00107	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.000754	0.00106	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000744	0.00104	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HRH3—narcolepsy	0.00074	0.00104	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CPT1B—narcolepsy	0.000739	0.00104	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.000728	0.00102	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.000727	0.00102	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.000727	0.00102	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—NPS—narcolepsy	0.000722	0.00101	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—TAC1—narcolepsy	0.000722	0.00101	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR ligand binding—HTR2A—narcolepsy	0.000718	0.00101	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.000707	0.00099	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HCRT—narcolepsy	0.000704	0.000986	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.000695	0.000973	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—TRH—narcolepsy	0.000685	0.000959	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—TAC1—narcolepsy	0.000675	0.000945	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—NPS—narcolepsy	0.000675	0.000945	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.000664	0.00093	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.000664	0.00093	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	0.000662	0.000926	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HCRT—narcolepsy	0.000657	0.000921	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—NPS—narcolepsy	0.000656	0.000919	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—TAC1—narcolepsy	0.000656	0.000919	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	0.00065	0.000911	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	0.00065	0.000911	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.000647	0.000906	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	0.000628	0.000879	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PENK—narcolepsy	0.000627	0.000878	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—TAC1—narcolepsy	0.000613	0.000858	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—NPS—narcolepsy	0.000613	0.000858	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.000603	0.000845	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.000603	0.000845	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	0.000601	0.000841	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CPT1B—narcolepsy	0.0006	0.000841	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.000591	0.000827	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PENK—narcolepsy	0.000586	0.000821	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	0.000584	0.000817	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.000577	0.000808	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000576	0.000806	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CPT1B—narcolepsy	0.000551	0.000772	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	0.000548	0.000768	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	0.000548	0.000768	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HCRT—narcolepsy	0.000534	0.000748	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TRH—narcolepsy	0.000533	0.000747	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CPT1B—narcolepsy	0.00052	0.000728	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.000518	0.000725	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TRH—narcolepsy	0.000498	0.000698	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—NPS—narcolepsy	0.000498	0.000697	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	0.000498	0.000697	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.00049	0.000687	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CHKB—narcolepsy	0.000488	0.000683	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000481	0.000674	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PENK—narcolepsy	0.000476	0.000666	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HRH3—narcolepsy	0.000468	0.000655	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.000437	0.000612	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HRH3—narcolepsy	0.000437	0.000612	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000435	0.000609	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.00043	0.000602	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000429	0.000601	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000429	0.000601	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR2A—narcolepsy	0.000406	0.000568	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TRH—narcolepsy	0.000405	0.000567	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.0004	0.000559	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR2A—narcolepsy	0.000395	0.000553	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000391	0.000548	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TAC1—narcolepsy	0.000388	0.000543	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NPS—narcolepsy	0.000388	0.000543	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR2A—narcolepsy	0.000369	0.000516	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000363	0.000508	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TAC1—narcolepsy	0.000362	0.000507	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NPS—narcolepsy	0.000362	0.000507	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.000356	0.000499	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.000356	0.000499	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HRH3—narcolepsy	0.000355	0.000497	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000331	0.000464	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.00033	0.000462	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000299	0.000419	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NPS—narcolepsy	0.000294	0.000412	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TAC1—narcolepsy	0.000294	0.000412	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.000258	0.000362	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR2A—narcolepsy	0.000233	0.000326	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR2A—narcolepsy	0.000218	0.000305	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.000214	0.0003	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	0.000177	0.000248	CbGpPWpGaD
